FDA Panel Weighs Pain Drugs' Benefits, Risks (Reuters)


Reuters - U.S. scientific advisers
began hearing evidence on Wednesday about the benefits and
risks of pain killers taken by millions of Americans as
regulators weigh moves following Merck & Co. Inc.'s recall of
its arthritis pill Vioxx.

Read more...